FDA Calls For Removal of Suicide Warnings
The FDA recently removed warnings regarding suicidal ideation for GLP-1 drugs like Ozempic after a comprehensive meta-analysis found no causal link. While monitoring continues due to the complex relationship between obesity and mental health, clinical data supports the drugs’ safety, as told by Rebeca Funes.
